Company Filing History:

12 out of 242

Mount Sinai School of Medicine

Icahn School of Medicine at Mount Sinai

where one patent can have more than one assignee

Years Active: 1984-2014

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8664272 - Composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia (2014-03-04),

2. 8399420 - Azacytidine analogues and uses thereof (2013-03-19),

3. 8158605 - Azacytidine analogues and uses thereof (2012-04-17),

4. 8106033 - Composition and methods for the treatment of proliferative diseases (2012-01-31),

5. 7510707 - PAR, a novel marker gene for breast and prostate cancers (2009-03-31),

6. 6590123 - Aminobenzoic acid derivatives having anti-tumorigenic activity, methods of making and using the same (2003-07-08),

7. 6294695 - Aminobenzoic acid derivatives having anti-tumorigenic activity methods of making and using the same (2001-09-25),

8. 6040146 - Detection of mammary tumor virus-like sequences in human breast cancer (2000-03-21),

9. 5888817 - Pituitary differentiaton factor and methods of use thereof (1999-03-30),

10. 5795740 - Pituitary differentiation factor and methods of use thereof (1998-08-18),

11. 5686247 - Detection of mammary tumor virus env gene-like sequences in human breast (1997-11-11),

12. 4666834 - Leukocyte adherence inhibition assay (1987-05-19),

13. 4455379 - Leukocyte adherence inhibition assay (1984-06-19),

Title: The Innovative Ventures of James F Holland: Transforming Treatments for Leukemia

Introduction: James F Holland, a distinguished inventor based in Scarsdale, NY, has left an indelible mark on the field of medicine with his groundbreaking patents. With a total of 13 patents to his name, Holland's work has significantly impacted the treatment of myelodysplastic syndrome and acute myeloid leukemia.

Latest Patents: Among his latest patents, one stands out for its potential to revolutionize cancer treatment. The composition and methods for the treatment of myelodysplastic syndrome and acute myeloid leukemia offer a novel approach. By utilizing specific compounds and DNA methyltransferase inhibitors, Holland's innovation holds promise for improved patient outcomes.

Additionally, his work on azacytidine analogues opens new avenues for therapeutic interventions in cancer. The compounds he has developed demonstrate exciting possibilities for advancing the field of oncology.

Career Highlights: James F Holland's expertise has been honed through his tenure at prestigious institutions such as Mount Sinai School of Medicine and Mount Sinai School of Medicine of the City University of New York. His dedication to research and innovation has led to significant contributions in the medical domain.

Collaborations: In his journey towards medical advancement, Holland has collaborated with esteemed professionals such as Micsunica Platica and Lewis R Silverman. Together, they have synergized their efforts to push the boundaries of traditional medicine and introduce novel approaches to treating leukemia.

Conclusion: James F Holland's exemplary work exemplifies the power of innovation in transforming healthcare. His patents not only reflect his ingenuity but also highlight his commitment to improving patient care. As a visionary in the field of oncology, Holland continues to inspire future generations of inventors and researchers to push the boundaries of what is possible in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.